Netherlands covid-19 gatherings pandemic Netherlands

Mylan and Pfizer delay Upjohn merger amid coronavirus pandemic

Reading now: 204
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Mylan’s merger with Pfizer’s off-patent branded drugs unit Upjohn is now expected to close in the second half of this year due to the coronavirus pandemic.

As a result of restrictions on large gatherings in the Netherlands, Mylan’s extraordinary general meeting of shareholders to approve certain matters for the transaction has been postponed from 27 April to 30 June.

There were no other amendments to previously announced terms or plans related to the merger, previously expected to close in mid-2020, said the companies.

Announcing the delay in the Upjohn transaction, the companies said: “The primary focus of both companies remains the health and safety of

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA